• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study

  • in General Medicine
  • — 2 Sep, 2007
Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
AudioMedica News
Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-330"/>
Stephen MacMahon
Stephen MacMahon
Raymond Gibbons
Raymond Gibbons

REFERENCE: Abstract 312 Hot Line 1 Sunday, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEPHEN MACMAHON, The George Institute, University of Sydney
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN

The randomised placebo controlled ADVANCE study of 11000 patients with diabetes has demonstrated that a combination of the ACE inhibitor, perindopril, with the diuretic indapamide can lower blood pressure and mortality. The investigators saw an impact even in patients who did not have high blood pressure. Lead study author Stephen MacMahon said this approach should be included in current practice guidelines. Sarah Maxwell spoke with him at the meeting in Vienna.
Raymond Gibbons commented on Stephen MacMahon’s presentation of the ADVANCE study.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070902_macmahon_gibbons.mp3]

You may also like...

  • Lytic Therapy Does Not Facilitate PCI Lytic Therapy Does Not Facilitate PCI 24 Feb, 2006
  • Colistin Use Linked to Outbreak of Rare Hospital Infection Colistin Use Linked to Outbreak of Rare Hospital Infection 23 Sep, 2007
  • Statins Protect Heart Patients from Sepsis Statins Protect Heart Patients from Sepsis 14 Feb, 2006
  • DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates 21 Sep, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Lifestyle and Heart Disease in Europe: A Growing Problem
  • Next story Drug Eluting Stents, Bare Metal Stents: No Survival Difference
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with…
    • Childhood Obesity—Whose Business Is It?
  • Home
  • General Medicine
  • Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study

© COPYRIGHT 2020 AUDIOMEDICA.COM.